Incretin drugmakers and the telehealth channel selling them.
Equal-weight performance of 5 GLP-1 / Weight Loss stocks (LLY, NVO, VKTX, AMGN, HIMS) as of the close on 2026-09-18: 1W -1.8%, 1M -11.9%, 3M -3.3%, 6M +13.6%, YTD -4.3%.
| Ticker | 1W | 1M | 3M | 6M | YTD |
|---|---|---|---|---|---|
| NVO | -0.5% | -7.5% | -5.8% | +17.4% | -15.0% |
| LLY | +1.3% | -8.2% | +4.6% | +26.6% | +7.3% |
| AMGN | +1.1% | -12.2% | +11.9% | +10.3% | +17.8% |
| VKTX | -8.1% | -14.5% | -10.4% | -10.9% | -17.6% |
| HIMS | -2.8% | -17.1% | -16.5% | +24.6% | -13.8% |
Returns are price returns from adjusted daily closes, updated once a day. Compare all 42 market themes on EquityBase.